Rifaximin in cirrhosis: when therapeutic drift meets antimicrobial stewardship.
Saved in:
| Title: | Rifaximin in cirrhosis: when therapeutic drift meets antimicrobial stewardship. |
|---|---|
| Authors: | Jalan R; Liver Failure Group, Institute for Liver and Disease Health, University College London, London, UK. Electronic address: r.jalan@ucl.ac.uk., Patel VC; Roger Williams Institute of Liver Studies, School of Immunology & Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, Foundation for Liver Research and King's College Hospital, London, UK., Shoaie S; Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, UK. |
| Source: | The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2026 Jun; Vol. 11 (6), pp. 538-540. Date of Electronic Publication: 2026 Apr 16. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-1253 (Electronic) NLM ISO Abbreviation: Lancet Gastroenterol Hepatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2468-1253 |
|---|---|
| DOI: | 10.1016/S2468-1253(26)00076-2 |
